A Short Sequence Targets Transmembrane Proteins to Primary Cilia.
Published version
Peer-reviewed
Repository URI
Repository DOI
Type
Change log
Authors
Abstract
Primary cilia are finger-like sensory organelles that extend from the bodies of most cell types and have a distinct lipid and protein composition from the plasma membrane. This partitioning is maintained by a diffusion barrier that restricts the entry of non-ciliary proteins, and allows the selective entry of proteins harboring a ciliary targeting sequence (CTS). However, CTSs are not stereotyped and previously reported sequences are insufficient to drive efficient ciliary localisation across diverse cell types. Here, we describe a short peptide sequence that efficiently targets transmembrane proteins to primary cilia in all tested cell types, including human neurons. We generate human-induced pluripotent stem cell (hiPSC) lines stably expressing a transmembrane construct bearing an extracellular HaloTag and intracellular fluorescent protein, which enables the bright, specific labeling of primary cilia in neurons and other cell types to facilitate studies of cilia in health and disease. We demonstrate the utility of this resource by developing an image analysis pipeline for the automated measurement of primary cilia to detect changes in their length associated with altered signaling or disease state.
Description
Peer reviewed: True
Acknowledgements: We thank David Mick for generously providing the Cilia-Apex construct, the IMCD3 FLP-In line, and for helpful discussions that improved this manuscript. We thank Anne White for providing anti-αMSH antibody, Michael Ward, Mariam Aslanyan, Ronald Roepman, and Jiami Guo for sharing reagents, Ilona Zvetkova from the Gene Editing Core facility for her help in the design of the cloning strategies, Antony Hynes-Allen and Eugene Seah for their assistance with cloning, and Gregory Strachan and Chris Smith of the Tissue and Cell Imaging core facility for their assistance with the Opera Phenix confocal microscope and Harmony analysis software. IMS core facilities are funded by the UK Medical Research Council (MRC) Metabolic Disease Unit (MRC_MC_UU_00014/5) and a Wellcome Trust Major Award (208363/Z/17/Z). We support inclusive, diverse, and equitable conduct of research.
Publication status: Published
Journal Title
Conference Name
Journal ISSN
2073-4409
Volume Title
Publisher
Publisher DOI
Rights and licensing
Sponsorship
New York Stem Cell Foundation (NYSCF-R-156)
MRC (2623114)
BBSRC (BB/W005905/1)
Wellcome Trust (208363/Z/17/Z)
Wellcome Trust (210481/Z/18/Z)
MRC (MC_UU_00014/5)